Eversana Sustainability Profile
Eversana, officially known as Eversana Life Science Services, is a leading provider of commercial services for the life sciences industry, headquartered in the United States. Founded in 2018, the company has rapidly established itself as a key player in the healthcare sector, offering a comprehensive suite of solutions that span market access, patient support, and commercialisation strategies. With a strong presence across North America and Europe, Eversana is dedicated to enhancing patient outcomes through innovative services tailored to the unique needs of biopharmaceutical companies. Their core offerings, including integrated market access and patient engagement solutions, set them apart by ensuring that therapies reach the patients who need them most. Eversana's commitment to excellence has earned it a notable position in the market, recognised for its ability to drive efficiency and improve patient experiences in an increasingly complex healthcare landscape.
DitchCarbon Score
How does Eversana's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Eversana's score of 23 is lower than 65% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Eversana's reported carbon emissions
Eversana, headquartered in the United States, currently does not report any specific carbon emissions data, as indicated by the absence of figures in the latest emissions report. However, the company has made significant commitments towards climate action. Eversana is actively engaged in setting near-term reduction targets, with a status of "Committed" as of January 2024. While no long-term targets or net-zero commitments have been established, the company is focused on improving its sustainability practices within the pharmaceuticals, biotechnology, and life sciences sector. Eversana's climate initiatives are not cascaded from any parent organisation, indicating that their commitments and strategies are developed independently. The company is part of a growing movement within its industry to address climate change, although specific numerical targets or achievements have yet to be disclosed. As Eversana continues to evolve its climate strategy, stakeholders can expect further developments in its emissions reduction efforts.
How Carbon Intensive is Eversana's Industry?
How Carbon Intensive is Eversana's Location?
Eversana's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eversana has established climate goals through participation in recognized frameworks and target-setting initiatives. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
